EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Efficacy and Safety of Poly-L-Lactic Acid Microspheres for Temporal Hollowing Correction: A Multicenter, Randomized, No-Treatment–Controlled, Evaluator-Blinded Trial

Wenyun Ting, Binghan Wang, Xiangsheng Ding, Hongwei Liu, Haiyan Cui, Jianmin Yang, Zhehu Jin, Nanze Yu, Xiao Long

Aesthetic Plastic Surgery · 04.11.2026

DOI: 10.1007/s00266-026-06372-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Aesthetic Plastic Surgery, online erschienen am 04.11.2026. Verfasst von Wenyun Ting und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Plastic and Aesthetic Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical Colleg…. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Novapath Medical Device Technology (Yantai) Co., Ltd.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Temporal hollowing may reflect constitutional craniofacial morphology, acquired soft-tissue loss, or age-related change. High-quality evidence specifically validating poly-L-lactic acid (PLLA) for temporal augmentation remains sparse. This study evaluated the efficacy, safety, and durability of PLLA microspheres for temporal hollowing correction.

Methods

In a multicenter, randomized, evaluator-blinded trial, 162 adults with mild-to-severe bilateral temporal hollowing (Allergan Temple Hollowing Scale [ATHS] grades 2–4) were randomized (2:1) to PLLA microspheres (up to 3 sessions) or no treatment. The primary endpoint was the blinded-evaluator-assessed ATHS responder rate at Month 6. Secondary endpoints, interpreted as exploratory, included ATHS responder rates at Months 1, 3, 9, and 12, 3D volumetric changes, Global Aesthetic Improvement Scale (GAIS), and subject satisfaction/pain assessments.

Results

The Full Analysis Set included 161 subjects. At Month 6, the ATHS responder rate was 80.2% (PLLA) versus 1.8% (Control) (difference: 78.4%; 95% CI 68.1%–85.9%; P < 0.001). Early efficacy was observed (Month 1: 65.3%; Month 3: 76.5%). By Month 6, 95.8% of treated subjects self-reported aesthetic improvement. 3D imaging showed a mean volume increase of 0.66 mL in PLLA subjects versus small negative mean changes of 0.37–0.44 mL in controls. Responder rates were 91.7% at Month 9 and 89.5% at Month 12. Device-related adverse events occurred in 8.5%, with no device-related serious AEs.

Conclusions

PLLA microspheres provided significant, progressive, and durable correction of temporal hollowing compared with no treatment, with a favorable safety profile. Level of Evidence V This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .

Schlagwörter

Stichwörter der Autor:innen

Facial rejuvenationInjectable fillersPoly-L-lactic acid (PLLA)Temporal hollowing

Autor:innen und Institutionen

  • Department of Plastic and Aesthetic Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, People's Republic of China.
  • Department of Burn and Plastic Surgery of the First People's Hospital of Lianyungang, Lianyungang, Jiangsu Province, People's Republic of China.
  • Department of Plastic Surgery of the First Affiliated Hospital of Jinan University, Key Laboratory of Regenerative Medicine of Ministry of Education, Institute of New Technology of Plastic Surgery of Jinan University, G…
  • Department of Plastic and Cosmetic Surgery, Tongji Hospital, School of Medicine, Tongji University, Shanghai, 200092, People's Republic of China.
  • Institute of Aesthetic Plastic Surgery and Medicine, School of Medicine, Tongji University, Shanghai, 200065, People's Republic of China.
  • Department of Plastic and Reconstructive Surgery, Beijing Tsinghua Changgung Hospital, 168 Litang Road, Changping District, Beijing, People's Republic of China.

Förderung

  • Novapath Medical Device Technology (Yantai) Co., Ltd

Zitieren

APA

Ting, W., Wang, B., Ding, X., Liu, H., Cui, H., Yang, J., Jin, Z., Yu, N., & Long, X. (2026). Efficacy and Safety of Poly-L-Lactic Acid Microspheres for Temporal Hollowing Correction: A Multicenter, Randomized, No-Treatment–Controlled, Evaluator-Blinded Trial. Aesthetic Plastic Surgery. https://doi.org/10.1007/s00266-026-06372-3

Vancouver

Ting W, Wang B, Ding X, Liu H, Cui H, Yang J, et al. Efficacy and Safety of Poly-L-Lactic Acid Microspheres for Temporal Hollowing Correction: A Multicenter, Randomized, No-Treatment–Controlled, Evaluator-Blinded Trial. Aesthetic Plastic Surgery. 2026. doi:10.1007/s00266-026-06372-3

BibTeX
@article{Ting2026,
  author = {Ting, Wenyun and Wang, Binghan and Ding, Xiangsheng and Liu, Hongwei and Cui, Haiyan and Yang, Jianmin and Jin, Zhehu and Yu, Nanze and Long, Xiao},
  title = {Efficacy and Safety of Poly-L-Lactic Acid Microspheres for Temporal Hollowing Correction: A Multicenter, Randomized, No-Treatment–Controlled, Evaluator-Blinded Trial},
  journal = {Aesthetic Plastic Surgery},
  year = {2026},
  doi = {10.1007/s00266-026-06372-3}
}
Kostenlos starten →